[{"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-001", "question": "A 68-year-old man with metastatic castration-resistant prostate cancer (mCRPC) on enzalutamide presents with progressive dyspnea and fatigue. He has no chest pain or fever. His oxygen saturation is 88% on room air. CT pulmonary angiography shows no pulmonary embolism, but reveals diffuse ground-glass opacities with peripheral sparing. Bronchoalveolar lavage shows lymphocytic predominance with CD4:CD8 ratio of 0.3. Which of the following is the most appropriate next step in management?", "options": ["Discontinue enzalutamide and initiate high-dose corticosteroids", "Initiate empiric broad-spectrum antibiotics for atypical pneumonia", "Add abiraterone to his current regimen and continue enzalutamide", "Perform transbronchial biopsy to rule out lymphangitic carcinomatosis", "Start therapeutic-dose low-molecular-weight heparin for occult pulmonary embolism"], "answer": "A", "answer_index": 0, "explanation": "This presentation is classic for enzalutamide-induced interstitial pneumonitis, which typically presents with subacute dyspnea, ground-glass opacities on CT, and a lymphocytic BAL with low CD4:CD8 ratio. Immediate discontinuation of the offending agent and initiation of corticosteroids is the standard management. Antibiotics are not indicated without infectious signs, and adding abiraterone would exacerbate the drug-induced lung injury.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most appropriate next step in management, I'll analyze the clinical presentation and findings.\n\nThe patient presents with:\n- Progressive dyspnea and fatigue\n- Hypoxemia (88% on room air)\n- CT showing diffuse ground-glass opacities with peripheral sparing\n- Bronchoalveolar lavage with lymphocytic predominance and low CD4:CD8 ratio (0.3)\n- Currently on enzalutamide for mCRPC\n- No pulmonary embolism on CT angiography\n\nThese findings are highly suggestive of drug-induced pneumonitis, specifically enzalutamide-induced pneumonitis. The key features supporting this diagnosis are:\n- Temporal relationship with enzalutamide therapy\n- Ground-glass opacities on CT\n- Lymphocytic predominance in BAL with inverted CD4:CD8 ratio\n- Exclusion of pulmonary embolism and absence of infectious symptoms\n\nFor drug-induced pneumonitis, the standard management is to:\n1. Discontinue the offending agent (enzalutamide)\n2. Initiate corticosteroids to reduce inflammation\n\nThe other options are less appropriate:\n- Empiric antibiotics (B): No fever or evidence of infection\n- Adding abiraterone (C): Would not address the pulmonary toxicity\n- Transbronchial biopsy (D): Unnecessary given the diagnostic BAL findings\n- Anticoagulation (E): PE has been ruled out by CT angiography\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-002", "question": "A 4-month-old previously healthy infant presents with acute onset of irritability, vomiting, and lethargy. Physical examination reveals a bulging anterior fontanelle, retinal hemorrhages, and no focal neurologic deficits. Non-contrast head CT shows bilateral subdural hematomas of different ages. The infant's coagulation studies and metabolic panel are normal. Which of the following additional findings would most strongly support a diagnosis of glutaric aciduria type 1 rather than non-accidental trauma?", "options": ["Metaphyseal corner fractures on skeletal survey", "Elevated serum ammonia level", "Frontotemporal atrophy with widened Sylvian fissures on MRI", "Subarachnoid hemorrhage extending into the posterior fossa", "Elevated urine organic acids showing 3-hydroxyglutaric aciduria"], "answer": "E", "answer_index": 4, "explanation": "While glutaric aciduria type 1 can mimic non-accidental trauma with acute encephalopathy and subdural hematomas, the definitive diagnosis requires demonstration of elevated urine organic acids, specifically 3-hydroxyglutaric aciduria. Frontotemporal atrophy (option C) is a characteristic neuroimaging finding but is not diagnostic. Metaphyseal fractures strongly suggest abuse, while elevated ammonia suggests a different metabolic disorder.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "To differentiate between glutaric aciduria type 1 and non-accidental trauma in this infant with subdural hematomas, I need to consider the distinguishing features of each condition.\n\nGlutaric aciduria type 1 (GA1) is an inherited metabolic disorder that can present with subdural hematomas and can mimic child abuse. Key features of GA1 include:\n- Characteristic neuroimaging findings (frontotemporal atrophy, widened Sylvian fissures)\n- Biochemical abnormalities (elevated glutaric acid and 3-hydroxyglutaric acid in urine)\n- Macrocephaly\n- Acute encephalopathic crises\n\nLet's analyze each option:\n\nA. Metaphyseal corner fractures - These are highly specific for non-accidental trauma, not GA1.\n\nB. Elevated serum ammonia - While some metabolic disorders cause hyperammonemia, this is not a characteristic finding in GA1.\n\nC. Frontotemporal atrophy with widened Sylvian fissures - This is a classic neuroimaging finding in GA1, often described as \"bat-wing\" appearance.\n\nD. Subarachnoid hemorrhage in posterior fossa - This is more consistent with trauma than GA1.\n\nE. Elevated urine organic acids showing 3-hydroxyglutaric aciduria - This is the definitive diagnostic test for GA1, showing the specific metabolic abnormality.\n\nWhile option C shows a characteristic neuroimaging finding of GA1, option E provides the definitive diagnostic evidence through biochemical testing that would most strongly support GA1 over non-accidental trauma.\n\nThe answer is (E)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-003", "question": "A 55-year-old woman with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) who failed CAR T-cell therapy 3 months ago presents with new-onset confusion and myoclonus. MRI brain shows symmetric diffusion restriction in the bilateral thalami, basal ganglia, and cerebral cortex. EEG demonstrates periodic sharp wave complexes. CSF shows 12 white cells/mm³ (90% lymphocytes), normal glucose, and elevated protein at 80 mg/dL. Which of the following is the most likely causative agent?", "options": ["Tafasitamab", "Polatuzumab vedotin", "Tisagenlecleucel", "Blinatumomab", "Brentuximab vedotin"], "answer": "C", "answer_index": 2, "explanation": "This presentation is classic for CAR T-cell therapy-related immune effector cell-associated neurotoxicity syndrome (ICANS), which can occur weeks to months after treatment. The MRI pattern of symmetric deep gray matter and cortical involvement with corresponding EEG findings is characteristic. Tisagenlecleucel is a CD19-directed CAR T-cell therapy used in DLBCL. The other agents are monoclonal antibodies or antibody-drug conjugates not typically associated with this specific delayed neurotoxicity pattern.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "D", "model_outputs": "To answer this question, I need to analyze the clinical presentation and consider which of the listed agents could cause these neurological symptoms.\n\nThe patient presents with:\n- Confusion and myoclonus\n- MRI showing symmetric diffusion restriction in thalami, basal ganglia, and cerebral cortex\n- EEG with periodic sharp wave complexes\n- CSF with mild pleocytosis and elevated protein\n\nThese findings are consistent with encephalopathy. Let me evaluate each option:\n\nA. Tafasitamab: An anti-CD19 monoclonal antibody with minimal CNS toxicity profiles.\n\nB. Polatuzumab vedotin: An antibody-drug conjugate targeting CD79b. While it can cause peripheral neuropathy, it's not typically associated with this pattern of encephalopathy.\n\nC. Tisagenlecleucel: A CD19-directed CAR T-cell therapy that can cause immune effector cell-associated neurotoxicity syndrome (ICANS). This can present with confusion, encephalopathy, and seizures. The timing (3 months post-therapy) is somewhat atypical but possible.\n\nD. Blinatumomab: A bispecific T-cell engager (BiTE) that targets CD19 and CD3. It is well-known to cause encephalopathy, confusion, tremor, seizures, and other neurological symptoms that can match this presentation. The EEG findings with periodic sharp wave complexes are particularly consistent with blinatumomab neurotoxicity.\n\nE. Brentuximab vedotin: An anti-CD30 antibody-drug conjugate primarily used for Hodgkin lymphoma and anaplastic large cell lymphoma, not typically for DLBCL. It causes peripheral neuropathy but not this pattern of encephalopathy.\n\nBased on the clinical presentation, particularly the EEG findings and the pattern of encephalopathy, blinatumomab is the most likely causative agent among the options provided.\n\nThe answer is (D)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-004", "question": "A critically ill patient with septic shock on norepinephrine (0.3 mcg/kg/min) and vasopressin (0.03 units/min) develops refractory hypotension. Transthoracic echocardiogram shows a hyperdynamic left ventricle with collapsing mitral inflow pattern. Which of the following interventions is most likely to improve hemodynamics without increasing myocardial oxygen demand?", "options": ["Initiate dobutamine infusion at 5 mcg/kg/min", "Add phenylephrine infusion to target MAP >65 mmHg", "Administer 500 mL 5% albumin bolus", "Start angiotensin II infusion at 20 ng/kg/min", "Increase norepinephrine to 0.5 mcg/kg/min"], "answer": "D", "answer_index": 3, "explanation": "The echocardiographic findings suggest distributive shock with relative hypovolemia. Angiotensin II acts via AT1 receptors to cause vasoconstriction without significant inotropic effects, making it ideal for this scenario without increasing myocardial oxygen demand. Dobutamine increases myocardial demand, phenylephrine causes pure alpha-agonism with potential reflex bradycardia, fluid bolus may be insufficient in vasoplegic shock, and increasing norepinephrine adds beta-1 effects that increase oxygen consumption.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to analyze the patient's condition and the hemodynamic effects of each proposed intervention.\n\nThe patient has:\n- Septic shock with refractory hypotension\n- Already on high-dose norepinephrine and vasopressin\n- Hyperdynamic left ventricle (suggesting preserved cardiac function)\n- Collapsing mitral inflow pattern (suggesting hypovolemia/preload deficiency)\n\nLet's evaluate each option:\n\nA. Dobutamine: An inotrope that increases cardiac output but also increases myocardial oxygen demand, which we want to avoid.\n\nB. Phenylephrine: A pure alpha-1 agonist that increases vascular resistance but doesn't address the likely hypovolemia and may increase afterload and myocardial work.\n\nC. Albumin bolus: Would address the hypovolemia suggested by the collapsing mitral inflow pattern without directly increasing myocardial oxygen demand.\n\nD. Angiotensin II: A vasoconstrictor that increases blood pressure but doesn't address the likely hypovolemia.\n\nE. Increasing norepinephrine: Would further increase vasoconstriction but also increases myocardial oxygen demand and doesn't address the hypovolemia.\n\nGiven the echocardiographic findings suggesting hypovolemia, fluid administration would be most appropriate to improve preload without increasing myocardial oxygen demand.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-005", "question": "A 7-year-old boy presents with acute cerebellar ataxia following varicella infection 2 weeks prior. MRI shows T2 hyperintensity restricted to the cerebellar hemispheres. CSF demonstrates 15 lymphocytes/mm³, normal glucose, and elevated IgG index. Which of the following autoantibodies is most specific for this condition?", "options": ["Anti-GAD65", "Anti-Hu", "Anti-Yo", "Anti-Tr/DNER", "Anti-mGluR1"], "answer": "D", "answer_index": 3, "explanation": "Post-varicella acute cerebellar ataxia is associated with anti-Tr/DNER (delta/notch-like epidermal growth factor-related receptor) antibodies in a significant proportion of cases. This antibody is highly specific for paraneoplastic cerebellar degeneration in Hodgkin lymphoma but also occurs in post-infectious contexts. Anti-Yo and anti-Hu are associated with gynecological/breast cancers and small cell lung cancer respectively. Anti-mGluR1 is seen in Hodgkin-related ataxia, while anti-GAD65 is associated with stiff-person syndrome.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "To answer this question, I need to identify which autoantibody is most specifically associated with post-varicella acute cerebellar ataxia.\n\nThe case describes:\n- 7-year-old boy with acute cerebellar ataxia\n- Recent varicella (chickenpox) infection 2 weeks prior\n- MRI showing T2 hyperintensity in cerebellar hemispheres\n- CSF with mild lymphocytic pleocytosis and elevated IgG index\n\nPost-infectious cerebellar ataxia following varicella is typically immune-mediated. Among the antibodies listed:\n\nA. Anti-GAD65: Associated with stiff-person syndrome and some cases of cerebellar ataxia, but not specifically post-varicella.\n\nB. Anti-Hu: Associated with paraneoplastic encephalomyelitis and sensory neuropathy, typically in small cell lung cancer.\n\nC. Anti-Yo: Associated with paraneoplastic cerebellar degeneration, typically in gynecological or breast cancers.\n\nD. Anti-Tr/DNER: Associated with cerebellar ataxia in Hodgkin lymphoma and is known to target the Delta/Notch-like epidermal growth factor-related receptor in the cerebellum.\n\nE. Anti-mGluR1: Associated with cerebellar ataxia following viral infections, particularly varicella-zoster virus. This antibody targets metabotropic glutamate receptor 1, which is highly expressed in Purkinje cells of the cerebellum.\n\nBased on the clinical presentation of post-varicella cerebellar ataxia, the most specific autoantibody would be anti-mGluR1.\n\nThe answer is (E)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-006", "question": "A 42-year-old woman with newly diagnosed Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) achieves complete morphological remission after induction chemotherapy. Minimal residual disease (MRD) testing by flow cytometry shows 0.01% blasts. Which of the following factors would most strongly indicate proceeding to allogeneic hematopoietic stem cell transplantation in first complete remission rather than continuing with chemotherapy plus a tyrosine kinase inhibitor?", "options": ["Presence of IKZF1 deletion", "Age >40 years", "MRD positivity after consolidation therapy", "White blood cell count >30,000/μL at diagnosis", "Presence of additional cytogenetic abnormalities besides t(9;22)"], "answer": "C", "answer_index": 2, "explanation": "In Ph+ ALL, MRD positivity after consolidation therapy is the strongest predictor of poor outcome with chemotherapy/TKI alone and is a clear indication for allogeneic transplantation in first remission. While age >40, high WBC, IKZF1 deletion, and additional abnormalities are adverse prognostic factors, contemporary TKI-based regimens can overcome many of these. Persistent MRD after intensive therapy indicates resistant disease requiring transplant for cure.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "For Philadelphia chromosome-positive ALL (Ph+ ALL), I need to evaluate which factor most strongly indicates the need for allogeneic stem cell transplantation in first complete remission.\n\nLet me analyze each option:\n\nA. IKZF1 deletion - While this is associated with poor outcomes in ALL, it's not the strongest indication for transplant in Ph+ ALL.\n\nB. Age >40 years - Age alone is not the most compelling factor for transplantation in Ph+ ALL.\n\nC. MRD positivity after consolidation therapy - Persistent MRD after consolidation is one of the strongest predictors of relapse in Ph+ ALL. MRD persistence indicates that the leukemia is not fully responding to current therapy, significantly increasing relapse risk.\n\nD. White blood cell count >30,000/μL at diagnosis - While this is a poor prognostic factor, it's not as strong an indication for transplant as persistent MRD.\n\nE. Additional cytogenetic abnormalities - These can worsen prognosis but aren't as definitive as persistent MRD for transplant decisions.\n\nPersistent MRD after consolidation (option C) is the strongest indication for proceeding to transplant, as it directly demonstrates inadequate response to current therapy.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-007", "question": "A 65-year-old man with atrial fibrillation on apixaban presents with acute onset of aphasia and right hemiparesis. CT head shows a 3 cm left MCA territory infarct with no hemorrhage. Last apixaban dose was 4 hours ago. NIH Stroke Scale is 18. Which of the following is the most appropriate acute intervention?", "options": ["Administer intravenous tissue plasminogen activator immediately", "Give 4-factor prothrombin complex concentrate followed by tPA", "Perform emergent mechanical thrombectomy without thrombolysis", "Administer andexanet alfa followed by mechanical thrombectomy", "Give idarucizumab empirically followed by mechanical thrombectomy"], "answer": "C", "answer_index": 2, "explanation": "For large vessel occlusion strokes in patients on direct oral anticoagulants (DOACs) with recent dosing, mechanical thrombectomy without thrombolysis is recommended due to the increased risk of hemorrhagic transformation with tPA. Andexanet alfa is a reversal agent for factor Xa inhibitors but is not routinely recommended prior to thrombectomy unless there is life-threatening bleeding. Idarucizumab is for dabigatran reversal. PCC before tPA still carries bleeding risk and delays intervention.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "C", "model_outputs": "To answer this question, I need to consider the patient's clinical presentation, current anticoagulation status, and evidence-based stroke management guidelines.\n\nThe patient has:\n- Acute stroke symptoms (aphasia and right hemiparesis)\n- Confirmed ischemic stroke on CT (3 cm left MCA territory infarct)\n- High NIHSS score of 18 (indicating severe stroke)\n- Currently anticoagulated with apixaban (taken 4 hours ago)\n\nFor patients on direct oral anticoagulants (DOACs) like apixaban:\n- IV tPA (option A) is contraindicated within 48 hours of last DOAC dose due to bleeding risk\n- 4-factor PCC (option B) is used to reverse warfarin, not apixaban\n- Andexanet alfa (option D) is a reversal agent for apixaban but would only be indicated for hemorrhage, not ischemic stroke\n- Idarucizumab (option E) is a reversal agent for dabigatran, not apixaban\n\nGiven the patient is on apixaban with a recent dose, the safest and most appropriate intervention would be mechanical thrombectomy without thrombolysis (option C), as this avoids the bleeding risks associated with thrombolytic therapy in an anticoagulated patient.\n\nThe answer is (C)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-008", "question": "A 3-year-old child with DiGeorge syndrome (22q11.2 deletion) presents with hypocalcemic seizures. Correction of calcium with intravenous calcium gluconate and calcitriol is initiated. Which of the following immunologic parameters, if present, would be an absolute contraindication to live viral vaccination?", "options": ["CD4+ T cell count <500 cells/μL", "Absent thymic shadow on chest radiograph", "Low but detectable T cell receptor excision circles (TRECs)", "Severely reduced proliferative response to phytohemagglutinin", "Complete absence of CD3+ T cells by flow cytometry"], "answer": "E", "answer_index": 4, "explanation": "Complete absence of CD3+ T cells indicates severe combined immunodeficiency (SCID) phenotype within DiGeorge spectrum, which is an absolute contraindication to live vaccines due to risk of disseminated infection. Reduced proliferative responses (option D) indicate functional impairment but not complete absence. Low TRECs suggest poor thymic output but not necessarily SCID. CD4 count and thymic shadow are not definitive contraindications alone.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "E", "model_outputs": "To answer this question, I need to consider which immunologic parameter would represent an absolute contraindication to live viral vaccination in a child with DiGeorge syndrome.\n\nDiGeorge syndrome (22q11.2 deletion) is associated with thymic hypoplasia or aplasia, leading to varying degrees of T-cell immunodeficiency. The severity of immunodeficiency determines whether live viral vaccines are contraindicated.\n\nLet's analyze each option:\n\nA. CD4+ T cell count <500 cells/μL - This represents a moderate reduction but not complete absence of T-cell function.\n\nB. Absent thymic shadow on chest radiograph - While suggestive of thymic hypoplasia, this radiographic finding alone doesn't definitively indicate complete T-cell dysfunction.\n\nC. Low but detectable TRECs - This indicates some thymic function is present, even if reduced.\n\nD. Severely reduced proliferative response to phytohemagglutinin - This shows impaired T-cell function but not complete absence.\n\nE. Complete absence of CD3+ T cells by flow cytometry - This indicates complete T-cell deficiency, which would be an absolute contraindication to live viral vaccines due to the risk of vaccine-strain infection.\n\nThe answer is (E)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-009", "question": "A patient with glioblastoma on temozolomide and dexamethasone develops progressive headache, visual changes, and diabetes insipidus. MRI shows thickening and enhancement of the pituitary stalk with loss of the posterior pituitary bright spot. CSF cytology is negative. Which of the following findings would most strongly support a diagnosis of lymphocytic hypophysitis over pituitary metastasis?", "options": ["Presence of anti-pituitary antibodies", "Elevated CSF beta-2 transferrin", "Simultaneous involvement of the pineal gland", "Rapid improvement with high-dose corticosteroids", "Association with other autoimmune endocrine deficiencies"], "answer": "E", "answer_index": 4, "explanation": "Lymphocytic hypophysitis frequently presents with other autoimmune endocrine deficiencies (thyroiditis, adrenalitis, diabetes mellitus type 1), while pituitary metastases typically occur in isolation. Anti-pituitary antibodies have poor sensitivity/specificity. CSF beta-2 transferrin indicates CSF leak. Pineal involvement suggests germinoma. Steroid responsiveness occurs in both conditions but is more dramatic in hypophysitis; however, association with other autoimmune conditions is more specific.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "A", "model_outputs": "To determine the most supportive finding for lymphocytic hypophysitis versus pituitary metastasis in this glioblastoma patient, I'll analyze each option:\n\nA. Presence of anti-pituitary antibodies - Anti-pituitary antibodies are characteristic markers of autoimmune hypophysitis. They directly support an autoimmune etiology rather than metastatic disease.\n\nB. Elevated CSF beta-2 transferrin - This is a marker for CSF leakage, typically seen in skull base fractures, not specifically associated with either hypophysitis or metastasis.\n\nC. Simultaneous involvement of the pineal gland - This would actually favor metastatic spread rather than hypophysitis, as multifocal involvement suggests dissemination.\n\nD. Rapid improvement with high-dose corticosteroids - While hypophysitis may respond to steroids, this patient is already on dexamethasone, and response to steroids can occur in both conditions.\n\nE. Association with other autoimmune endocrine deficiencies - The presence of other autoimmune endocrine disorders (like Hashimoto's thyroiditis, Addison's disease) strongly suggests an autoimmune process affecting the pituitary, supporting lymphocytic hypophysitis.\n\nThe answer is (A)"}, {"quiz_id": "20251205T084024622Z_deepseek-v3.2_seed125", "question_id": "20251205T084024622Z_deepseek-v3.2_seed125-010", "question": "A neonate born at 32 weeks gestation develops necrotizing enterocolitis (NEC) on day 10 of life. During laparotomy, approximately 40% of the small bowel appears necrotic. Which of the following intraoperative findings would mandate creation of a high jejunostomy rather than primary anastomosis?", "options": ["Involvement of the ileocecal valve", "Necrosis extending to within 5 cm of the ligament of Treitz", "Presence of pneumatosis intestinalis in the remaining bowel", "Concurrent isolated perforation of the gastric fundus", "Development of abdominal compartment syndrome during surgery"], "answer": "B", "answer_index": 1, "explanation": "Necrosis extending to within 5 cm of the ligament of Treitz indicates near-total small bowel loss, requiring high jejunostomy to preserve the maximal possible length of viable bowel for future adaptation and prevent anastomotic leakage in compromised tissue. Ileocecal valve involvement is important for absorption but doesn't dictate anastomosis vs ostomy. Pneumatosis may be present in non-necrotic bowel. Gastric perforation is managed separately. Abdominal compartment syndrome may require temporary closure but not necessarily jejunostomy.", "generator_model": "deepseek-v3.2", "seed": 125, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "pred": "B", "model_outputs": "To determine the best answer, I need to consider which finding would necessitate a high jejunostomy rather than primary anastomosis in a neonate with NEC.\n\nA. Involvement of the ileocecal valve - While this is concerning, it doesn't specifically mandate a high jejunostomy. The ileocecal valve is distal, and its involvement would affect the distal anastomosis site.\n\nB. Necrosis extending to within 5 cm of the ligament of Treitz - This is critical because the ligament of Treitz marks the duodenojejunal junction. If necrosis extends this proximally, there would be insufficient viable proximal jejunum to perform a safe primary anastomosis. With only 5 cm of viable jejunum proximally, a high jejunostomy would be the safer option.\n\nC. Pneumatosis intestinalis in the remaining bowel - While concerning for ongoing disease, this finding alone doesn't necessarily mandate a jejunostomy if the tissue appears otherwise viable.\n\nD. Concurrent isolated perforation of the gastric fundus - This would require repair but doesn't specifically mandate a jejunostomy for the small bowel resection.\n\nE. Abdominal compartment syndrome - This might require temporary abdominal closure but doesn't specifically dictate the type of intestinal reconstruction.\n\nThe answer is (B)"}]